Editas Medicine

-$2.17 (-5.05%) Today

$0.00 (0.00%) As of 9:06 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).

CEO

James C. Mullen

Employees

235

Headquarters

Cambridge, Massachusetts

Founded

2013

EDIT Key Statistics

Market Cap

2.77B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.44M

High Today

$42.63

Low Today

$40.21

Open Price

$42.47

Volume

1.02M

52 Week High

$99.95

52 Week Low

$27.01

EDIT News

Benzinga4h

Analyzing Editas Medicine's Unusual Options Activity

On Friday, shares of Editas Medicine (NASDAQ:EDIT) saw unusual options activity. After the option alert, the stock price moved down to $40.88. Sentiment: BULLI

Simply Wall StJul 18

Do Institutions Own Editas Medicine, Inc. Shares?

The big shareholder groups in Editas Medicine, Inc. (NASDAQ:EDIT) have power over the company. Generally speaking, as a company grows, institutions will increas

Analyst Ratings

40%

of 15 ratings

Buy

33.3%

Hold

40%

Sell

26.7%

EDIT Earnings

-$1.00

-$0.63

-$0.25

$0.12

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 5, Pre-Market